uk-dfsrh MCQ (SBA): Drospirenone POP ACE Inhibitor Hyperkalaemia Risk

Instant feedback + full explanation. One question, done properly.

ModeratePrescribing & PharmacologyDrospirenone POP ACE Inhibitor Hyperkalaemia Riskuk-dfsrh

A 40-year-old woman on the drospirenone POP also takes an ACE inhibitor for hypertension. What is the specific concern?

Educational content. Not a substitute for clinical judgement or local policy.

uk-dfsrh MCQ: Drospirenone POP ACE Inhibitor Hyperkalaemia Risk — Answ